PHRM.L Share News (PHRM)

PHRM.L Information

There is currently no data for PHRM

Tuesday tips round-up: Carillion, Phorm

Tue, 09th Dec 2014 08:23

Carillion has been "through the wars" as one analyst recently put it, after de-scaling its British construction business and the odd negative publicity surrounding its relationship with suppliers. However, a recent run of contract wins should put to rest any doubts about the company's work pipeline. The announcement that it has sealed a deal to re-develop the main stand at Anfield, for Liverpool FC's stadium, is simply the most well-known example. Furthermore, should rival Balfour Beatty finally be broken up then it may get a second chance to make off with the rest of that company. Nevertheless, the firm continues to face margins under pressure in Canada, as a result of weakness in the energy services market. The shares are a strong hold but until it gets that second chance the upside is limited, says The Times's Tempus.Targeted online advertising technology provider Phorm was once worth £35 a share. The uproar over its Webwise product however did the stock in. The service, which profiled internet users to deliver advertising set off a storm of controversy. That led clients such as Amazon.com and BT to abandon the service. The stock is now trading at just 10p despite the fact that its rivals have developed and deployed similar technologies. Neither did the recent round of fundraising do the company's market capitalisation many favours. Avoid, Tempus says.

More News

14 Apr 2016 15:36

Phorm finally fizzles out, leaving shareholders with nought

(ShareCast News) - Phorm's controversial time on the stock market stumbled toward an ignominious end on Thursday as the notorious money-pit failed to find further funding, its nominated adviser Strand Hanson threw in the towel and a winding-up process began. Long-suffering shareholders, including th

14 Apr 2016 09:15

Phorm Ceasing Activities, Nomad Resigns As It Fails To Secure Funding

16 Mar 2016 16:00

Suspended Phorm raises fresh capital through note issue

(ShareCast News) - Advertising technology company Phorm had £350,000 more cash in its pocket on Wednesday, after issuing convertible loan notes in the amount to existing shareholder Michael Bigger. In accordance with the terms of the convertible loan note instrument, interest would accrue on the uns

25 Feb 2016 09:35

Phorm Shares Suspended As It Fails To Secure Final Funding Tranche (ALLISS)

4 Feb 2016 18:25

Phorm Corp Makes Progress On Fundraising Efforts (ALLISS)

1 Feb 2016 16:32

Phorm In Flurry Of Financing Arrangements To Secure Future (ALLISS)

21 Jan 2016 09:40

Phorm Secures TRUSTe Data Collection Privacy Certfication

18 Jan 2016 09:45

Phorm Corp Raises USD1 Million As It Tries To Cut Cash Burn Rate (ALLISS)

6 Nov 2015 09:37

Phorm Raises GBP2.1 Million For General Working Capital (ALLISS)

28 Oct 2015 07:57

Phorm Corp Teams Up With INSOMNIS Media To Improve Campaigns

20 Oct 2015 09:16

Phorm selected to help Causemo profile potential donors

(ShareCast News) - Phorm has teamed up with Causemo to improve the identification of and personalised communication with potential donors online. The AIM listed advertising-technology company announced the deal on Tuesday with the US charitable causes donation market innovator. It will use Phorm's

20 Oct 2015 06:46

Phorm Inks Deal With Boston-Based Fundraising Firm Causemo

13 Oct 2015 09:14

Phorm appoints new chief revenue officer

(ShareCast News) - Phorm Corporation has hired David Paquette as the company's new chief revenue officer. The appointment, announced Tuesday, is expected to "cultivate and accelerate sales of the company's technology platform, particularly in the US". Paquette brings 15 years of sales experience in

13 Oct 2015 07:11

Phorm Appoints David Paquette As Chief Revenue Officer

9 Oct 2015 09:41

Boston Globe to implement Phorm's ad technology

(ShareCast News) - Phorm Corporation has signed a deal for Boston Globe Media Group to use its advertising technology on the media group's digital properties. The company announced the deal on Friday, which will use its Machine-Learning Artificial Intelligence technology to identify and target speci

Latest Share Chat

PHRM.L Share News (PHRM)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday tips round-up: Carillion, Phorm

Login to your account

Quickpicks are a member only feature

Login to your account